Clinical controversies in thrombolytic therapy for the management of acute pulmonary embolism.
about
Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem.Systemic thrombolysis for acute pulmonary embolism.Practice patterns and complication rates of thrombolysis for pulmonary embolism.Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study.
P2860
Clinical controversies in thrombolytic therapy for the management of acute pulmonary embolism.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical controversies in thro ...... t of acute pulmonary embolism.
@en
Clinical controversies in thro ...... t of acute pulmonary embolism.
@nl
type
label
Clinical controversies in thro ...... t of acute pulmonary embolism.
@en
Clinical controversies in thro ...... t of acute pulmonary embolism.
@nl
prefLabel
Clinical controversies in thro ...... t of acute pulmonary embolism.
@en
Clinical controversies in thro ...... t of acute pulmonary embolism.
@nl
P2860
P356
P1433
P1476
Clinical controversies in thro ...... t of acute pulmonary embolism.
@en
P2093
Mitchell J Daley
P2860
P304
P356
10.1002/PHAR.1051
P407
P577
2012-02-01T00:00:00Z